Fredric N Eshelman's Net Worth

$268 Million

Estimate Recalculated Apr 23, 2024 04:25PM EST

Who is Fredric N Eshelman?

Fredric N Eshelman has an estimated net worth of $268 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., G1 Therapeutics, Inc., Amplitude Healthcare Acquisition Corp, EYENOVIA, INC., Aravive, Inc., Furiex Pharmaceuticals, Inc., PHARMACEUTICAL PRODUCT DEVELOPMENT INC, Liquidia Technologies Inc, MEDICINES CO /DE, and Liquidia Corp.

SEC CIK

Fredric N Eshelman's CIK is 0001033409

Past Insider Trading and Trends

2011 was Fredric N Eshelman's most active year for acquiring shares with 27 total transactions. Fredric N Eshelman's most active month to acquire stocks was the month of April. 2007 was Fredric N Eshelman's most active year for disposing of shares, totalling 687 transactions. Fredric N Eshelman's most active month to dispose stocks was the month of April. 2021 saw Fredric N Eshelman paying a total of $20,958,750.00 for 2,914,428 shares, this is the most they've acquired in one year. In 2011 Fredric N Eshelman cashed out on 8,736,470 shares for a total of $245,790,118.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $8.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
+115.21%
20.5K
$9.66
-$47,372.64
38.3K
May 3 - May 5
Form 4
-0.15%
-26.00
$23.78
-$618.28
17.8K
Jul 1
Form 4
+1,526.09%
16.73K
—
—
17.82K
Jun 17
Form 4
∞
1.1K
—
—
1.1K
Mar 11
Form 3
—
0
—
—
0
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $4.795

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
250K
$19.73
$4,932,500.00
250K
Nov 13
Form 4
—
0
—
—
0
Jul 11
Form 4
∞
3.44M
$15.00
—
3.44M
May 22
Form 3
—
0
—
—
0
No matching records found

Amplitude Healthcare Acquisition Corp (JSPR) Snapshot price: $17.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

EYENOVIA, INC. (EYEN) Snapshot price: $1.7984

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.54%
6.96K
—
—
1.3M
Nov 17
Form 4
+0.57%
7.29K
—
—
1.29M
Sep 11
Form 4
+0.63%
8.04K
—
—
1.29M
Aug 16
Form 4
+0.32%
4.03K
—
—
1.28M
Jul 24
Form 4
+35.70%
335K
$10.00
$3,350,000.00
1.27M
Jan 29
Form 3
—
0
—
—
0
No matching records found

Aravive, Inc. (ARAV) No price found

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+177.01%
16.31M
$0.92
$14,999,999.79
25.52M
Oct 24
Form 4
—
0
—
—
0
Sep 23
Form 4
+97.41%
4.55M
—
$454.55
9.21M
Apr 1
Form 4
+22.60%
860.22K
$2.33
$2,000,002.20
4.67M
Mar 29
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Sep 10
Form 4
+308.78%
2.88M
$7.29
$20,958,750.00
3.81M
Feb 12
Form 4
—
0
—
—
0
Sep 14
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found